ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
Health economics of Parkinson's disease prevention: why early detection matters in low- and middle-income countries.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) will become the second leading cause of death globally. This rising trend is expected to be even more pronounced in Asia, where six of the most populous countries are located, in countries with a middle socio-demographic index, and in low- to middle-income countries (LMICs) where resources and healthcare system are limited, causing greater public health burden and placing substantial demands to the patient's family, caregiver, community, and the society. The care of patients with PD requires a multidisciplinary approach to manage complex motor and nonmotor symptoms needing a team of specialists, availability of diagnostic tests, and pharmacologic and non-pharmacologic treatments. More often, this approach is not readily available in LMICs and involves a high out-of-pocket expenditure. Improving early detection of both motor and non-motor symptoms facilitate early management, improving quality of life, lessening the economic burden on patients, caregivers, families, and ultimately, the healthcare system.
Indexed as
Identifiers
42762334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.